Myeloablative chemotherapy in testicular cancer patient

• Authors: Karolina Furgała , Zuzanna Smuniewska , Dawid Sigorski , Maciej Michalak , Lubomir Bodnar
• Languages of publication: EN

Abstracts

EN

Chemotherapy is the standard treatment for metastatic testicular cancers. The autologous hematopoietic stem cell transplantation is a salvage option for relapsed patients. The paper presents a case of a 20-year-old patient with stage IIIC non-seminoma treated with BEP chemotherapy and autologous transplantation of stem cells, which allowed to achieve durable remission.

Keywords

EN

autologous hematopoietic stem cell transplantation; chemotherapy; non-seminoma

Discipline

• MEDICINE: MEDICINE

• Publisher: Medical Education
• Journal: OncoReview
• Year: 2021
• Volume: 11
• Issue: 1
• Pages: 19-21

Contributors

author

Karolina Furgała

• Collegium Medicum, University of Warmia and Mazury

author

Zuzanna Smuniewska

• Collegium Medicum, University of Warmia and Mazury

author

Dawid Sigorski

• 1. Department of Oncology, Collegium Medicum, University of Warmia and Mazury. 2. Clinical Department of Oncology and Immuno-Oncology, Warmian-Masurian Cancer Center of The Ministry of The Interior and Administration’s Hospital, Olsztyn, Poland

author

Maciej Michalak

• 1. Department of Oncology, Collegium Medicum, University of Warmia and Mazury. 2. Department of Radiology, Warmian-Masurian Cancer Center of The Ministry of The Interior and Administration’s Hospital, Olsztyn, Poland

author

Lubomir Bodnar

• 1. Department of Oncology, Collegium Medicum, University of Warmia and Mazury. 2. Clinical Department of Oncology and Immuno-Oncology, Warmian-Masurian Cancer Center of The Ministry of The Interior and Administration’s Hospital, Olsztyn, Poland

References

• 1. Mead GM, Stenning SP; Clinical Oncology Editorial. The International Germ Cell Consensus Classification: A New Prognostic Factor-Based Staging Classification for Metastatic Germ Cell Tumours. Clin Oncol (R Coll Radiol). 1997; 9(4): 207-9.
• 2. Einhorn LH, Williams SD, Chamness A et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007; 357: 340-8.
• 3. McHugh DJ, Feldman DR. Conventional-dose versus high-dose chemotherapy for relapsed germ cell tumors. Adv Urol. 2018; 2018:7272541.
• 4. Lorch A, Bascoul-Mollevi C, Kramar A et al. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. J Clin Oncol. 2011; 29: 2178-84.
• 5. Feldman DR, Sheinfeld J, Bajorin DF et al. TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. J Clin Oncol. 2010; 28: 1706-13.

• Document Type: article